Glaukos Stock Analysis

GKOS -  USA Stock  

USD 49.92  0.08  0.16%

The big decline in price over the last few months for Glaukos Corpmay raise some interest from retail investors. The stock closed today at a share price of 49.92 on 309,300 in trading volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in June. However, diversifying your holdings with Glaukos Corp or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.88. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Glaukos Corp partners.
Please check Risk vs Return Analysis.

Search Stock Analysis 

The Glaukos Corp stock analysis report makes it easy to digest most publicly released information about Glaukos Corp and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Glaukos Stock analysis module also helps to analyze the Glaukos Corp price relationship with some important fundamental indicators such as market cap and management efficiency.

Glaukos Stock Analysis Notes

About 109.0% of the company shares are owned by institutional investors. The book value of Glaukos Corp was currently reported as 12.82. The company recorded a loss per share of 1.84. Glaukos Corp had not issued any dividends in recent years. Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California. Glaukos Corp operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 653 people. To learn more about Glaukos Corp call Thomas Burns at 949 367-9600 or check out

Glaukos Corp Quarterly Cost of Revenue

16.63 MillionShare

Glaukos Corp Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Glaukos Corp's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Glaukos Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Glaukos Corp generates negative expected return over the last 90 days
Glaukos Corp has high historical volatility and very poor performance
The company reported the previous year's revenue of 237.59 M. Net Loss for the year was (82.76 M) with profit before overhead, payroll, taxes, and interest of 157.95 M.
Glaukos Corp currently holds about 407.38 M in cash with (5.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.81.
Glaukos Corp has a poor financial position based on the latest SEC disclosures
Latest headline from White House official was infected with COVID-19, has mild symptoms -White House - Yahoo Finance

Glaukos Corp Upcoming and Recent Events

Earnings reports are used by Glaukos Corp to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Glaukos Corp previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report5th of August 2021
Next Earnings Report4th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End24th of February 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Glaukos Largest EPS Surprises

Earnings surprises can significantly impact Glaukos Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Glaukos Corp SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Glaukos Corp prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Glaukos Corp investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Glaukos Corp specific information freely available to individual and institutional investors to make a timely investment decision.
20th of July 2021
Regulation FD Disclosure
9th of June 2021
Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
5th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
4th of March 2021
Financial Statements and Exhibits. Regulation FD Disclosure
1st of March 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
25th of February 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
12th of February 2021
Unclassified Corporate Event
10th of February 2021
Unclassified Corporate Event

Glaukos Corp Thematic Classifications

In addition to having Glaukos Corp stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

Glaukos Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 2.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Glaukos Corp's market, we take the total number of its shares issued and multiply it by Glaukos Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Glaukos Profitablity

Glaukos Corp's profitability indicators refer to fundamental financial ratios that showcase Glaukos Corp's ability to generate income relative to its revenue or operating costs. If, let's say, Glaukos Corp is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Glaukos Corp's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Glaukos Corp's profitability requires more research than a typical breakdown of Glaukos Corp's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (34.83) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (28.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.29.
Last ReportedProjected for 2021
Return on Investment(14.98) (16.16) 
Return on Average Assets(0.13) (0.14) 
Return on Average Equity(0.18) (0.20) 
Return on Invested Capital(0.22) (0.24) 
Return on Sales(0.53) (0.57) 

Management Efficiency

The entity has return on total asset (ROA) of (4.7) % which means that it has lost $4.7 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (13.45) %, meaning that it created substantial loss on money invested by shareholders. Glaukos Corp management efficiency ratios could be used to measure how well glaukos corp manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/24/2021, Return on Investment is likely to drop to -16.16. In addition to that, Return on Average Assets is likely to drop to -0.14. Glaukos Corp Asset Turnover is relatively stable at the moment as compared to the past year. Glaukos Corp reported last year Asset Turnover of 0.24. As of 07/24/2021, Average Assets is likely to grow to about 1 B, while Return on Average Assets are likely to drop (0.14) .
Last ReportedProjected for 2021
Book Value per Share 15.00  16.18 
Enterprise Value over EBIT(30.00) (30.79) 
Enterprise Value over EBITDA(42.59) (45.95) 
Price to Book Value 5.07  5.77 
Tangible Assets Book Value per Share 13.07  10.92 
Enterprise Value3.6 B2.9 B
Tangible Asset Value581.7 M627.6 M

Technical Drivers

As of the 24th of July, Glaukos Corp retains the market risk adjusted performance of 1.28, and Risk Adjusted Performance of (0.15). Glaukos Corp technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Glaukos Corp, which can be compared to its competitors. Please check out Glaukos Corp coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Glaukos Corp is priced fairly, providing market reflects its last-minute price of 49.92 per share. Given that Glaukos Corp has jensen alpha of (0.81), we strongly advise you to confirm Glaukos Corp's regular market performance to make sure the company can sustain itself at a future point.

Glaukos Corp Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Exponential Moving Average is calculated by weighting recent values of Glaukos Corp more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Glaukos Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Glaukos Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Glaukos Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Glaukos Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Glaukos Corp Predictive Daily Indicators

Glaukos Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Glaukos Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Glaukos Corp Forecast Models

Glaukos Corp time-series forecasting models is one of many Glaukos Corp's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Glaukos Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Glaukos Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Glaukos Corp stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Glaukos shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Glaukos Corp. By using and applying Glaukos Stock analysis, traders can create a robust methodology for identifying Glaukos entry and exit points for their positions.
Last ReportedProjected for 2021
Operating Margin(54.92) (56.37) 
EBITDA Margin(0.37) (0.40) 
Gross Margin 0.59  0.65 
Profit Margin(0.54) (0.55) 
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California. Glaukos Corp operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 653 people.

Current Glaukos Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Glaukos analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Glaukos analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Glaukos Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Glaukos analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Glaukos stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Glaukos Corp, talking to its executives and customers, or listening to Glaukos conference calls.
Glaukos Analyst Advice Details

Glaukos Stock Analysis Indicators

Glaukos Corp stock analysis indicators help investors evaluate how Glaukos Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Glaukos Corp shares will generate the highest return on investment. By understating and applying Glaukos Corp stock analysis, traders can identify Glaukos Corp position entry and exit signals to maximize returns.
Quick Ratio1.32
Fifty Two Week Low39.58
Revenue Growth22.80%
Shares Short Prior Month4.21M
Average Daily Volume Last 10 Day1.67M
Average Daily Volume In Three Month447.81k
Shares Percent Shares Out8.05%
Gross Margins74.40%
Short Percent Of Float14.23%
Forward Price Earnings-58.45
Float Shares44.84M
Fifty Two Week High99.00
Enterprise Value To Ebitda-101.25
Fifty Day Average77.99
Two Hundred Day Average84.02
Enterprise Value To Revenue16.32
Please check Risk vs Return Analysis. Note that the Glaukos Corp information on this page should be used as a complementary analysis to other Glaukos Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Glaukos Stock analysis

When running Glaukos Corp price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
The market value of Glaukos Corp is measured differently than its book value, which is the value of Glaukos that is recorded on the company's balance sheet. Investors also form their own opinion of Glaukos Corp's value that differs from its market value or its book value, called intrinsic value, which is Glaukos Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Glaukos Corp's market value can be influenced by many factors that don't directly affect Glaukos Corp underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Glaukos Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine Glaukos Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Glaukos Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.